Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population

Abstract

Background Airflow obstruction is a hallmark of chronic obstructive pulmonary disease (COPD), and is defined as either the ratio between forced expiratory volume in one second and forced vital capacity (FEV 1 /FVC) < 70% or < lower limit of normal (LLN). This study aimed to assess the overlap between genome-wide association studies (GWAS) on airflow obstruction using these two definitions in the same population stratified by smoking. Methods GWASes were performed in the LifeLines Cohort Study for both airflow obstruction definitions in never-smokers (NS = 5071) and ever-smokers (ES = 4855). The FEV 1 /FVC < 70% models were adjusted for sex, age, and height; FEV 1 /FVC < LLN models were not adjusted. Ever-smokers models were additionally adjusted for pack-years and current-smoking. The overlap in significantly associated SNPs between the two definitions and never/ever-smokers was assessed using several p -value thresholds. To quantify the agreement, the Pearson correlation coefficient was calculated between the p -values and ORs. Replication was performed in the Vlagtwedde-Vlaardingen study (NS = 432, ES = 823). The overlapping SNPs with p < 10 − 4 were validated in the Vlagtwedde-Vlaardingen and Rotterdam Study cohorts (NS = 1966, ES = 3134) and analysed for expression quantitative trait loci (eQTL) in lung tissue ( n = 1087). Results In the LifeLines cohort, 96% and 93% of the never- and ever-smokers were classified concordantly based on the two definitions. 26 and 29% of the investigated SNPs were overlapping at p < 0.05 in never- and ever-smokers, respectively. At p < 10 − 4 the overlap was 4% and 6% respectively, which could be change findings as shown by simulation studies. The effect estimates of the SNPs of the two definitions correlated strongly, but the p-values showed more variation and correlated only moderately. Similar observations were made in the Vlagtwedde-Vlaardingen study. Two overlapping SNPs in never-smokers ( NFYC and FABP7) had the same direction of effect in the validation cohorts and the NFYC SNP was an eQTL for NFYC-AS1 . NFYC is a transcription factor that binds to several known COPD genes, and FABP7 may be involved in abnormal pulmonary development. Conclusions The definition of airflow obstruction and the population under study may be important determinants of which SNPs are associated with airflow obstruction. The genes FABP7 and NFYC(-AS1) could play a role in airflow obstruction in never-smokers specifi...

A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography

“…Interestingly, the observation that GRS-structure associations were independent of lung function could be consistent with lung structure indexing "preobstructive" disease (16,17) and/or nonobstructive emphysema or the "symptomatic smoking" phenotype (14,35,59). Future studies should examine causal pathways more precisely by leveraging structurespecific GWAS signals, subclassified COPD endotypes, and longitudinal measurements of disease incidence and progression (60,61).…”

LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins

“…There have been few studies regarding the function of NFYC-AS1. For instance, van der Plaat et al found that NFYC-AS1 may play a role in airflow obstruction in never smokers by analyzing the genome-wide association study (GWAS) data (15). However, the authors also did not further verify the function of NFYC-AS1 in cell lines or animal models.…”

Lifestyle factors related to prevalent chronic disease multimorbidity: A population-based cross-sectional study

“…We defined two phenotypes when assessing chronic respiratory disease: airflow obstruction and asthma. Airflow obstruction, assessed by pre-bronchodilator spirometry (measured using a Welch Allyn Version 1.6.0.489, PC-based SpiroPerfect with Ca Workstation software), was defined as a ratio between the forced expiratory volume in one second and the forced vital capacity (FEV 1 /FVC) below the lower limit of normal (LLN) [ 25 ]. The LLN reference value was based on age, gender, height and ethnicity, and was calculated as the lower fifth percentile of a healthy reference population [ 25 , 26 ].…”

“…Airflow obstruction, assessed by pre-bronchodilator spirometry (measured using a Welch Allyn Version 1.6.0.489, PC-based SpiroPerfect with Ca Workstation software), was defined as a ratio between the forced expiratory volume in one second and the forced vital capacity (FEV 1 /FVC) below the lower limit of normal (LLN) [ 25 ]. The LLN reference value was based on age, gender, height and ethnicity, and was calculated as the lower fifth percentile of a healthy reference population [ 25 , 26 ]. Asthma was considered present if either a doctor had made the diagnosis or the patient used asthma medication and reported two or more symptoms from among wheeze, dyspnea at rest, and wakened by dyspnea.…”